Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

Co-Diagnostics, Inc. (CODX) announced the release date for its first-quarter 2024 financial results, scheduled for May 9, 2024. The company will host a conference call and webcast to discuss the financial results with analysts and institutional investors. Management team members including CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson will participate in the call.

SALT LAKE CITY, April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors.  Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

The conference call and webcast will be available via:

Webcast: ir.codiagnostics.com on the Events & Webcasts page

Conference Call: 844-481-2661 (domestic) or 412-317-0652 (international)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-first-quarter-2024-earnings-release-date-and-webcast-302125958.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics, Inc. release its first-quarter 2024 financial results?

Co-Diagnostics, Inc. will release its first-quarter 2024 financial results on Thursday, May 9, 2024, after the market close.

Who will participate in the conference call and webcast to discuss Co-Diagnostics, Inc.'s financial results?

The management team members including CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson will participate in the conference call and webcast to discuss Co-Diagnostics, Inc.'s financial results.

Where can I access the webcast of Co-Diagnostics, Inc.'s financial results discussion?

You can access the webcast on ir.codiagnostics.com on the Events & Webcasts page.

How can I join the conference call to discuss Co-Diagnostics, Inc.'s financial results?

You can join the conference call by dialing 844-481-2661 for domestic participants or 412-317-0652 for international participants.

What should I do if I cannot participate in the live webcast of Co-Diagnostics, Inc.'s financial results discussion?

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.